Literature DB >> 412119

Effects of antiepileptic drugs on thalamocortical excitability.

R N Englander, R N Johnson, J J Brickley, G R Hanna.   

Abstract

Comparative effects of anticonvulsant drugs on the thalamocortical system were analyzed quantitatively. Paired stimuli were delivered to the ventrolateral thalamus with evoked responses recorded from the ipsilateral sensorimotor cortex in the cat. Threshold and excitability profiles were developed with an on-line computer. Effects of phenytoin and diazepam were generally similar, with depression of excitability and slight elevation of thresholds. Ethosuximide produced a pronounced pair-interval dependent effect of unchanged or increased excitability and lowered threshold at shorter intervals, with depressed excitability and raised threshold at longer intervals. These data demonstrate a marked difference in effect of the petit mal and grand mal agents tested and suggest a basis for the effectiveness of ethosuximide in controlling 3-per-second repetitive activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412119     DOI: 10.1212/wnl.27.12.1134

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Analysis of epileptic activity in a system of interconnected neurons. A biological criticality theory.

Authors:  G C Theodoridis; J D Charlton; W J Nowack; R N Johnson
Journal:  Ann Biomed Eng       Date:  1980       Impact factor: 3.934

2.  The effect of diphenylhydantoin on the electroretinogram.

Authors:  P Lachapelle; L Blain; M G Quigley; R C Polomeno; S Molotchnikoff
Journal:  Doc Ophthalmol       Date:  1989-12       Impact factor: 2.379

Review 3.  Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy.

Authors:  C L Faingold; R A Browning
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

Review 4.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.